Genmab A/SGMABNASDAQ
Loading
Cash Flow PerformanceStrong
Percentile Rank93
3Y CAGR+24.6%
5Y CAGR+3.3%
Studio
Year-over-Year Change

Cash generated from core business operations

3Y CAGR
+24.6%/yr
vs +40.1%/yr prior
5Y CAGR
+3.3%/yr
Recent acceleration
Acceleration
-15.5pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive declineStrong
PeriodValueYoY Change
2025$7.56B-2.7%
2024$7.77B+5.3%
2023$7.38B+88.7%
2022$3.91B+75.6%
2021$2.23B-65.4%
2020$6.43B+385.1%
2019$1.33B+30.7%
2018$1.01B-36.1%
2017$1.59B+384.9%
2016$327.72M-